Grant Life Cycle
Results & Data
In Moldova, Prison-based Harm Reduction Programs Prevent HIV and Protect Human Rights
Meet Rithy: Grandmother and Outreach Worker at the Heart of Cambodia’s HIV Response
To Detect Disease Threats, Mozambique Finds Answers in Wastewater
Rwanda’s Robust Digital Health Systems Vital in Fight Against COVID-19
18 February 2022
The U.S. Food and Drug Administration (FDA) has recently published a safety communication on Pulse Oximeter Accuracy and Limitations.
While the COVID-19 pandemic has caused an increase in the use of pulse oximeters, a recent report (Sjoding et al.) suggests that the devices may be less accurate in people with dark skin pigmentation.
The US FDA communication recalls that although pulse oximetry is useful for estimating blood oxygen levels, pulse oximeters have limitations and a risk of inaccuracy under certain circumstances that should be considered.